GRK2, G protein-coupled receptor kinase 2, 156

N. diseases: 159; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Left ventricular diastolic dysfunction
0.010 AlteredExpression disease BEFREE The GRK2-mRNA level in PBMCs of DM with LVDD was significantly higher than in DM control without LVDD. 31680450 2020
CUI: C0003864
Disease: Arthritis
Arthritis
0.010 AlteredExpression disease BEFREE CP-25 attenuates arthritis progression in animal models by inhibiting G protein-coupled receptor kinase 2 (GRK2) membrane expression. 30557832 2019
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.010 Biomarker disease BEFREE G-protein coupled receptor kinase 2 safeguards epithelial phenotype in Head and Neck Squamous Cell Carcinomas. 31850518 2019
CUI: C0021051
Disease: Immunologic Deficiency Syndromes
Immunologic Deficiency Syndromes
0.010 Biomarker group BEFREE The Influence of β-Adrenergic Receptor Kinase-1 on Stroke-induced Immunodeficiency Syndrome. 29601376 2019
CUI: C0025149
Disease: Medulloblastoma
Medulloblastoma
0.010 Biomarker disease BEFREE Here we report that GRK2 knockdown slowed cell growth, diminished proliferation, and enhanced cisplatin- and etoposide-induced apoptosis in medulloblastoma cell lines UW228-2 and Daoy. 31554835 2019
CUI: C0040411
Disease: Tongue Neoplasms
Tongue Neoplasms
0.010 AlteredExpression group BEFREE We uncover that G-protein-coupled receptor kinase-2 (GRK2) expression is reduced in undifferentiated, high-grade human HNSCC tumors, whereas its silencing in model human HNSCC cells is sufficient to trigger epithelial-to-mesenchymal transition (EMT) phenotypic features, an EMT-like transcriptional program and enhanced lymph node colonization from orthotopic tongue tumors in mice. 31850518 2019
CUI: C0278510
Disease: Childhood Medulloblastoma
Childhood Medulloblastoma
0.010 Biomarker disease BEFREE Here we report that GRK2 knockdown slowed cell growth, diminished proliferation, and enhanced cisplatin- and etoposide-induced apoptosis in medulloblastoma cell lines UW228-2 and Daoy. 31554835 2019
CUI: C0278876
Disease: Adult Medulloblastoma
Adult Medulloblastoma
0.010 Biomarker disease BEFREE Here we report that GRK2 knockdown slowed cell growth, diminished proliferation, and enhanced cisplatin- and etoposide-induced apoptosis in medulloblastoma cell lines UW228-2 and Daoy. 31554835 2019
CUI: C0496870
Disease: Benign neoplasm of liver
Benign neoplasm of liver
0.010 AlteredExpression disease BEFREE The mean serum levels of Ang II and TNF-α in normal subjects and patients with benign liver tumors (BLTs) and HCC were evaluated by enzyme-linked immunosorbent assay (ELISA), and liver samples from the patients with HCC and HCC mice were used to assess the protein levels of both cytokines, their major receptors and GRK2. 30712649 2019
CUI: C0679309
Disease: physical symptom
physical symptom
0.010 Biomarker phenotype BEFREE βARK1 was significantly associated with HFSPS scores (β = 0.22 ± 0.10, p = 0.038), adjusting for other predictors of physical symptoms (model R<sup>2</sup> = 0.250, F(7, 70) = 3.34, p = 0.004). 29803296 2019
CUI: C1135191
Disease: Heart Failure, Systolic
Heart Failure, Systolic
0.010 Biomarker disease BEFREE GRK2 appears a promising target, given its established role in insulin resistance and in systolic heart failure. 30934608 2019
Squamous cell carcinoma of the head and neck
0.010 AlteredExpression disease BEFREE Our results suggest that GRK2 safeguards the epithelial phenotype, whereas its downregulation contributes to the activation of EMT programs in HNSCC.This article is protected by copyright.All rights reserved. 31850518 2019
CUI: C2004489
Disease: Regurgitation
Regurgitation
0.010 Biomarker phenotype BEFREE Therefore, changes in the expression of β2-AR and GRK2 in PBMC of PR patients, could be considered as potential biomarkers to determine clinical decisions. 30837872 2019
CUI: C3160909
Disease: Autoimmune arthritis
Autoimmune arthritis
0.010 Biomarker disease BEFREE CP-25 reverses prostaglandin E4 receptor desensitization-induced fibroblast-like synoviocyte dysfunction via the G protein-coupled receptor kinase 2 in autoimmune arthritis. 30643209 2019
CUI: C0011616
Disease: Contact Dermatitis
Contact Dermatitis
0.010 AlteredExpression disease BEFREE Glutamine application resulted in a rapid and strong expression of GRK2 in not only dinitrochlorobenzene-induced CD (within 10 minutes) but also cultured rat dorsal root ganglion cells, F11 (within 1 minute). 29530536 2018
CUI: C0018798
Disease: Congenital Heart Defects
Congenital Heart Defects
0.010 GeneticVariation group BEFREE However, germ-line (but not cardiomyocyte-specific) GRK2 deletion provoked lethal fetal heart defects, suggesting an unexplained role for GRKs in heart development. 29969579 2018
CUI: C0018818
Disease: Ventricular Septal Defects
Ventricular Septal Defects
0.010 Biomarker group BEFREE GRK2/5/6 triple null mice at E14.5 exhibited left and right heart blood intermixing through single atrioventricular valves or large membranous ventricular septal defects. 29969579 2018
CUI: C0019348
Disease: Herpes Simplex Infections
Herpes Simplex Infections
0.010 Biomarker group BEFREE The effect of herpes simplex virus (HSV)-GRK2 amplicons to restore GRK2 levels or of an Epac inhibitor on PGE<sub>2</sub> allodynia in primed mice was examined. 29922165 2018
CUI: C0042769
Disease: Virus Diseases
Virus Diseases
0.010 Biomarker group BEFREE Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target. 30206219 2018
CUI: C0392514
Disease: Hereditary hemochromatosis
Hereditary hemochromatosis
0.010 Biomarker disease BEFREE The kinase GRK2 has been linked to the clinically important Hedgehog (HH) signaling pathway, where it is paradoxically required for signal transduction yet also promotes internalization and degradation of the critical HH signal transducer Smoothened. 29438011 2018
CUI: C0393642
Disease: Sepsis-Associated Encephalopathy
Sepsis-Associated Encephalopathy
0.010 Biomarker disease BEFREE Altogether, these results uncover the novel role for GRK2 in regulating cellular oxidative and nitrosative stress during inflammation and suggest that GRK2 may have a potential as an intriguing therapeutic target to prevent or treat SAE. 29500815 2018
CUI: C0520540
Disease: Rebound hypertension
Rebound hypertension
0.010 Biomarker disease BEFREE To test the effects of GRK2 inhibitotr, we measured blood pressure by using a tail-cuff system in diabetic mice in which rebound hypertension was induced by withdrawal after clonidine treatment and measured vascular responses in isolated aortas from these mice. 29463871 2018
CUI: C1719788
Disease: Episodic ataxia type 1
Episodic ataxia type 1
0.010 AlteredExpression disease BEFREE In rat EAM, treatment with gallein effectively improved survival and cardiac function, suppressed cardiac remodeling, and further attenuated myocardial protein expression of GRK2 as well as high mobility group box (HMGB)1 and its cascade signaling proteins. 30024944 2018
CUI: C1739395
Disease: Takotsubo Cardiomyopathy
Takotsubo Cardiomyopathy
0.010 AlteredExpression disease BEFREE Sequential biopsies in the recovery-phase for two patients with TTS revealed that membrane expression of GRK2 and β-arrestin2 faded over time. 30143703 2018
CUI: C1840311
Disease: Laryngeal cleft
Laryngeal cleft
0.010 Biomarker disease BEFREE To counteract vasoconstrictor-induced contraction, GPCR/PLC signaling can be desensitized by G protein-coupled receptor kinases (GRKs), with GRK2 playing a predominant role in isolated arterial smooth muscle cells. 29980659 2018